Literature DB >> 21686687

Working effectively with patients with comorbid mental illness and substance abuse: a case study using a structured motivational behavioural approach.

Sharon Lawn1, Rene G Pols, Malcolm W Battersby.   

Abstract

This case describes the use of innovative person-centred motivational behaviour change tools to enhance chronic condition self-management with a person with chronic paranoid schizophrenia, significant drug abuse and multiple psychosocial issues. In standard care, the complexity of this patient's presentation, their cognitive impairment level and history of violence would likely exclude them from many therapies and treatment programs as unsuitable or in the "too hard" basket. In fact, using a motivational and highly person-centred approach proved to be extremely necessary and rewarding for the person and their mental health worker. This approach provided a clear structure, actual tools and a clear rationale for what many would argue, yet is often ill-defined, was "just good clinical practice". However, it also facilitated the development of "something special" in the relationship between the person and their worker that is central to person-centred care. Through a semistructured, motivational, sequential process that encouraged gradual disclosure and greater self-awareness by the client and active listening by the worker, greater collaboration and shared responsibility was enhanced.

Entities:  

Year:  2009        PMID: 21686687      PMCID: PMC3027853          DOI: 10.1136/bcr.08.2008.0674

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Client experience of gender in therapeutic relationships: an interpretive ethnography.

Authors:  D R Gehart; R R Lyle
Journal:  Fam Process       Date:  2001

Review 2.  Criticisms and concerns of the transtheoretical model in light of recent research.

Authors:  J O Prochaska; C C DiClemente; W F Velicer; J S Rossi
Journal:  Br J Addict       Date:  1992-06

3.  Time for a change: putting the Transtheoretical (Stages of Change) Model to rest.

Authors:  Robert West
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

4.  SA HealthPlus: a controlled trial of a statewide application of a generic model of chronic illness care.

Authors:  Malcolm Battersby; Peter Harvey; P David Mills; Elizabeth Kalucy; R G Pols; Peter A Frith; Peter McDonald; Adrian Esterman; George Tsourtos; Ronald Donato; Rodney Pearce; Christopher McGowan
Journal:  Milbank Q       Date:  2007       Impact factor: 4.911

Review 5.  Functional cognitive-behavioural therapy: a brief, individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia.

Authors:  Corinne Cather
Journal:  Can J Psychiatry       Date:  2005-04       Impact factor: 4.356

6.  "Simply to be let in": inclusion as a basis for recovery.

Authors:  L Davidson; D A Stayner; C Nickou; T H Styron; M Rowe; M L Chinman
Journal:  Psychiatr Rehabil J       Date:  2001

7.  Impact of client and therapist gender on psychotherapy process and outcome.

Authors:  E E Jones; C L Zoppel
Journal:  J Consult Clin Psychol       Date:  1982-04

8.  The mental health expert patient: findings from a pilot study of a generic chronic condition self-management programme for people with mental illness.

Authors:  Sharon Lawn; Malcolm W Battersby; Rene G Pols; John Lawrence; Trevor Parry; Mick Urukalo
Journal:  Int J Soc Psychiatry       Date:  2007-01

Review 9.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  M Cleary; G Hunt; S Matheson; N Siegfried; G Walter
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  9 in total
  1 in total

1.  Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review.

Authors:  Kirsten Marchand; Scott Beaumont; Jordan Westfall; Scott MacDonald; Scott Harrison; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.